Ultraviolet B-Induced Skin Angiogenesis Is Associated with a Switch in the Balance of Vascular Endothelial Growth Factor and Thrombospondin-1 Expression

Journal of Investigative Dermatology

Volumn 122, Issue 1, 2004, Pages 201-208

  Yano, Kiichiro ^a,b   Kajiya, Kentaro ^a   Ishiwata, Miki ^a   Hong, Young Kwon ^b   Miyakawa, Tokichi ^c   Detmar, Michael ^b  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Acute UVB irradiation; Angiogenesis; Thrombospondin (TSP 1); Vascular regression

Indexed keywords

ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; CD36 ANTIGEN; MESSENGER RNA; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DERMIS; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; RADIATION DOSE; SKIN BLOOD FLOW; ULTRAVIOLET B RADIATION; UPREGULATION;

EID: 1642452808     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2003.22101.x     Document Type: Article

References (37)

1. Berton TR, Mitchell DL, Fischer SM, Locniskar MF: Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis. J Invest Dermatol 109:340-347, 1997
2. Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ: Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 111:864-872, 1998
3. Blaudschun R, Sunderkotter C, Brenneisen P, et al: Vascular endothelial growth factor causally contributes to the angiogenic response upon ultraviolet B irradiation in vivo. Br J Dermatol 146:581-587, 2002
4. Bleuel K, Popp S, Fusenig NE, Stanbridge EJ, Boukamp P: Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci USA 96:2065-2070, 1999
5. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 271:21793-21797, 1996
6. Braverman IM, Keh-Yen A: Three dimensional reconstruction of endothelial cell gaps in psoriatic vessels and their morphologic identity with gaps produced by the intradermal injection of histamine. J Invest Dermatol 86:577-581, 1986
7. Brown LF, Harrist TJ, Yeo KT, et al: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 104:744-749, 1995a
8. Brown LF, Olbricht SM, Berse B, et al: Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 154:2801-2807, 1995b
9. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, Van De Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-1379, 1992
10. Cox NH, Diffey BL, Farr PM: The relationship between chronological age and the erythemal response to ultraviolet B radiation. Br J Dermatol 126:315-319, 1992
11. Dejana E, Corada M, Lampugnani MG: Endothelial cell-to-cell junctions. FASEB J 9:910-918, 1995
12. Detmar M: The role of VEGF and thrombospondins In skin angiogenesis. J Dermatol Sci 24 (Suppl 1):S78-S84, 2000
13. Detmar M, Brown LF, Schön MP, et al: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111:1-6, 1998
14. Detmar M, Brown LF, Claffey KP, et al: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146, 1994
15. Detmar M, Yeo KT, Nagy JA, et al: Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105:44-50, 1995
16. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995
17. Hawighorst T, Oura H, Streit M, et al: Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 21:7945-7956, 2002
18. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N: Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6:41-48, 2000
19. Kerstens HM, Poddighe PJ, Hanselaar AG: A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 43:347-352, 1995
20. Kishimoto J, Ehama R, Ge Y, Kobayashi T, Nishiyama T, Detmar M, Burgeson RE: In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Am J Pathol 157:103-110, 2000
21. Kligman LH: The ultraviolet-irradiated hairless mouse: A model for photoaging. J Am Acad Dermatol 21:623-631, 1989
22. Kramer M, Sachsenmaier C, Herrlich P, Rahmsdorf HJ: UV irradiation-induced interleukin-1 and basic fibroblast growth factor synthesis and release mediate part of the UV response. J Biol Chem 268:6734-6741, 1993
23. Kripke ML: Ultraviolet radiation and immunology: Something new under the sun - Presidential address. Cancer Res 54:6102-6105, 1994
24. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO: Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101:982-992, 1998
25. Leyden JJ, Grove GL, Grove MJ, Thorne EG, Lufrano L: Treatment of photodamaged facial skin with topical tretinoin. J Am Acad Dermatol 21:638-644, 1989
26. Mildner M, Weninger W, Trautinger F, Ban J, Tschachler E: UVA and UVB radiation differentially regulate vascular endothelial growth factor expression in keratinocyte-derived cell lines and in human keratinocytes. Photochem Photobiol 70:674-679, 1999
27. Naganumaa M, Yagi E, Fukuda M: Delayed induction of pigmented spots on UVB-irradiated hairless mice. J Dermatol Sci 25:29-35, 2001
28. Pearse AD, Gaskell SA, Marks R: Epidermal changes in human skin following irradiation with either UVB or UVA. J Invest Dermatol 88:83-87, 1987
29. Prophet E, Mills B, Arrington J, Sobin L: Laboratory Methods in Histotechnology. 1-236-237. Washington (DC): American Registry of Pathology, 1992
30. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y: The AMeX method: A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 125:431-435, 1986
31. Streit M, Velasco P, Brown LF et al: Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155:441-452, 1999
32. Streit M, Velasco P, Riccardi L, et al: Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 19:3272-3282, 2000
33. Strickland I, Rhodes LE, Flanagan BF, Friedmann PS: TNF-alpha and IL-8 are upregulated in the epidermis of normal human skin after UVB exposure: Correlation with neutrophil accumulation and E-selectin expression. J Invest Dermatol 108:763-768, 1997
34. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497-511, 1993
35. Wight TN, Raugi GJ, Mumby SM, Bornstein P: Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem 33:295-302, 1985
36. Yano K, Brown LF, Detmar M: Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 107:409-417, 2001
37. Yano K, Oura H, Detmar M: Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage. J Invest Dermatol 118:800-805, 2002